Evaluation of lorlatinib efficacy of patients with EML4-ALK
Latest Information Update: 09 Dec 2020
At a glance
- Drugs Lorlatinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms Lorlatinib ctDNA
- 09 Dec 2020 New trial record